Asieris' subsidiary makes significant progress in its commercialization strategy by obtaining the "Drug Distribution License"
- Written by PR Newswire
SHANGHAI, April 10, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that its subsidiary, Hainan Yahong pharmaceutical Trading Co., Ltd. ("Hainan Asieris "),...














